Trials / Conditions / Stage III Nasopharyngeal Carcinoma AJCC v7
Stage III Nasopharyngeal Carcinoma AJCC v7
3 registered clinical trials studyying Stage III Nasopharyngeal Carcinoma AJCC v7 — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors NCT03074513 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer NCT02339558 | National Cancer Institute (NCI) | Phase 2 |
| Recruiting | Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and NCT01365169 | M.D. Anderson Cancer Center | N/A |